Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Thrombospondin-2 overexpression in the skin of transgenic mice reduces the susceptibility to chemically induced multistep skin carcinogenesis.

Kunstfeld R, Hawighorst T, Streit M, Hong YK, Nguyen L, Brown LF, Detmar M.

J Dermatol Sci. 2014 May;74(2):106-15. doi: 10.1016/j.jdermsci.2014.01.002. Epub 2014 Jan 18.

2.

Acute liver failure due to acute fatty liver of pregnancy.

Wand S, Waeschle RM, Von Ahsen N, Hawighorst T, Bräuer A, Quintel M.

Minerva Anestesiol. 2012 Apr;78(4):503-6. Epub 2011 Jun 17.

3.

Agonists and antagonists of GnRH-I and -II reduce metastasis formation by triple-negative human breast cancer cells in vivo.

Schubert A, Hawighorst T, Emons G, Gründker C.

Breast Cancer Res Treat. 2011 Dec;130(3):783-90. doi: 10.1007/s10549-011-1358-9. Epub 2011 Jan 30.

PMID:
21279682
5.

CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo.

Koch M, Hussein F, Woeste A, Gründker C, Frontzek K, Emons G, Hawighorst T.

Breast Cancer Res Treat. 2011 Jul;128(2):337-46. doi: 10.1007/s10549-010-1085-7. Epub 2010 Aug 17.

6.

Pentalogy of Cantrell vs. limb body wall complex: differential diagnosis of a severe malformation in early pregnancy.

Stein W, Haller F, Hawighorst T, Emons G.

Ultraschall Med. 2009 Dec;30(6):598-601. doi: 10.1055/s-0028-1109743. Epub 2009 Dec 7. No abstract available.

PMID:
19998210
7.

[Modern therapy concepts for endometrial cancer].

Emons G, Hellriegel M, Hawighorst T.

Pathologe. 2009 Jul;30(4):268-73. doi: 10.1007/s00292-009-1149-9. German.

PMID:
19495765
8.

[Long-term tococlysis with beta-2-mimetics--a retrospective analysis from one centre].

Stein W, Jahns B, Hawighorst T, Emons G.

Z Geburtshilfe Neonatol. 2009 Feb;213(1):18-22. doi: 10.1055/s-0028-1119412. Epub 2009 Mar 3. German.

PMID:
19259901
9.

[Surgical treatment of severe postpartum haemorrhage with uterine compression sutures as described by Pereira].

Stein W, Hawighorst T, Emons G.

Z Geburtshilfe Neonatol. 2008 Feb;212(1):18-21. doi: 10.1055/s-2008-1004687. Review. German.

PMID:
18293258
10.

Development of lymphatic vessels: tumour lymphangiogenesis and lymphatic invasion.

Wilting J, Hawighorst T, Hecht M, Christ B, Papoutsi M.

Curr Med Chem. 2005;12(26):3043-53. Review.

PMID:
16375699
11.
12.

[Angiogenesis, lymphangiogenesis, and tumor progression].

Hawighorst T.

Zentralbl Gynakol. 2002 Nov;124(11):497-505. Review. German.

PMID:
12796842
13.

Thrombospondin-1 selectively inhibits early-stage carcinogenesis and angiogenesis but not tumor lymphangiogenesis and lymphatic metastasis in transgenic mice.

Hawighorst T, Oura H, Streit M, Janes L, Nguyen L, Brown LF, Oliver G, Jackson DG, Detmar M.

Oncogene. 2002 Nov 14;21(52):7945-56.

14.

Activation of the tie2 receptor by angiopoietin-1 enhances tumor vessel maturation and impairs squamous cell carcinoma growth.

Hawighorst T, Skobe M, Streit M, Hong YK, Velasco P, Brown LF, Riccardi L, Lange-Asschenfeldt B, Detmar M.

Am J Pathol. 2002 Apr;160(4):1381-92.

15.

Systemic inhibition of tumor growth and angiogenesis by thrombospondin-2 using cell-based antiangiogenic gene therapy.

Streit M, Stephen AE, Hawighorst T, Matsuda K, Lange-Asschenfeldt B, Brown LF, Vacanti JP, Detmar M.

Cancer Res. 2002 Apr 1;62(7):2004-12.

16.

The angiogenesis inhibitor vasostatin does not impair wound healing at tumor-inhibiting doses.

Lange-Asschenfeldt B, Velasco P, Streit M, Hawighorst T, Pike SE, Tosato G, Detmar M.

J Invest Dermatol. 2001 Nov;117(5):1036-41.

17.

Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma.

Skobe M, Hamberg LM, Hawighorst T, Schirner M, Wolf GL, Alitalo K, Detmar M.

Am J Pathol. 2001 Sep;159(3):893-903.

18.

Thrombospondin-2 plays a protective role in multistep carcinogenesis: a novel host anti-tumor defense mechanism.

Hawighorst T, Velasco P, Streit M, Hong YK, Kyriakides TR, Brown LF, Bornstein P, Detmar M.

EMBO J. 2001 Jun 1;20(11):2631-40.

19.

Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis.

Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, Riccardi L, Alitalo K, Claffey K, Detmar M.

Nat Med. 2001 Feb;7(2):192-8.

PMID:
11175850
20.

Thrombospondin-1 suppresses wound healing and granulation tissue formation in the skin of transgenic mice.

Streit M, Velasco P, Riccardi L, Spencer L, Brown LF, Janes L, Lange-Asschenfeldt B, Yano K, Hawighorst T, Iruela-Arispe L, Detmar M.

EMBO J. 2000 Jul 3;19(13):3272-82.

21.

Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis.

Streit M, Riccardi L, Velasco P, Brown LF, Hawighorst T, Bornstein P, Detmar M.

Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):14888-93.

22.

Establishment of new epithelial carcinoma cell lines by blocking monolayer formation.

Hackenberg R, Hawighorst T, Hild F, Schulz KD.

J Cancer Res Clin Oncol. 1997;123(11-12):669-73.

PMID:
9620227
23.
24.

Regulation of androgen receptor mRNA and protein level by steroid hormones in human mammary cancer cells.

Hackenberg R, Hawighorst T, Filmer A, Slater EP, Bock K, Beato M, Schulz KD.

J Steroid Biochem Mol Biol. 1992 Dec;43(7):599-607.

PMID:
1472451

Supplemental Content

Loading ...
Support Center